OPTION CARE INC/DE
10-Q, 1997-11-14
HOME HEALTH CARE SERVICES
Previous: ICU MEDICAL INC/DE, 10-Q, 1997-11-14
Next: PLASTIC CONTAINERS INC, 10-Q, 1997-11-14



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C.  20549

                                   FORM 10-Q



         [X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

                 For the third quarter ended September 30, 1997
                                             ------------------


                        Commission file number 80-19878
                                               --------


                               OPTION CARE, INC.
                               -----------------
             (Exact name of registrant as specified in its charter)


            Delaware                                    36-3791193
- ---------------------------------           ---------------------------------
(State or other jurisdiction                (IRS Employer Identification No.)
of incorporation or organization)


100 Corporate North
Suite 212
Bannockburn, Illinois                                               60015
- ---------------------------------------                           ----------
(Address of principal executive office)                           (zip code)

Registrant's telephone number, including area code:        (847) 615-1690
                                                           --------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                           YES    X         NO  
                                -----           -----


Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.


            Class                             Outstanding as of October 31, 1997
- ----------------------------                  ----------------------------------
Common Stock - .01 par value                              10,709,855

                                       1
<PAGE>
 
                                     INDEX
                        OPTION CARE, INC. & SUBSIDIARIES

 
 
PART I                       FINANCIAL INFORMATION
 
Item 1.    Financial Statements (Unaudited)                             PAGE NO.
 
           Condensed Consolidated Balance Sheets - September 30, 1997
           and December 31, 1996.....................................         3
 
           Condensed Consolidated Statements of Operations -
           Three and Nine Months Ended September 30, 1997 and 1996...         4
 
           Consolidated Statement of Stockholders' Equity -
           Nine Months Ended September 30, 1997......................         5
 
           Condensed Consolidated Statements of Cash Flows -
           Nine Months Ended September 30, 1997 and 1996.............         6
 
           Notes to Condensed Consolidated Financial Statements......         7
 
Item 2.    Management's Discussion and Analysis of
           Financial Condition and Results of Operations.............         8
 


PART II    OTHER INFORMATION

Item 6.    Exhibits...................................................       11

                                       2
<PAGE>
 
                         PART I.  FINANCIAL INFORMATION
                       OPTION CARE, INC. AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                       (In thousands, except share data)
                                  (Unaudited)

                                     ASSETS
<TABLE>
<CAPTION>

                                                 September 30,  December 31,
                                                 -------------  ------------
                                                     1997           1996
                                                     ----           ----
<S>                                              <C>            <C>
Current assets:
  Cash and cash equivalents......................  $  1,170       $  1,223
  Accounts receivable, net.......................    34,254         20,558
  Inventories....................................     2,576          1,598
  Deferred income taxes..........................     1,154          1,154
  Other current assets...........................     4,763          4,283
                                                   --------       --------
      Total current assets.......................    43,917         28,816

Property and equipment, net......................     5,986          4,322
Goodwill.........................................    15,338          7,873
Other assets.....................................     3,833          3,030
                                                   --------       --------
      Total assets...............................  $ 69,074       $ 44,041
                                                   ========       ========

                      LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Current portion of long-term debt..............  $    280       $  1,399
  Trade accounts payable.........................     6,659          2,685
  Accrued wages & related employee benefits......     2,626          1,838
  Accrued expenses...............................     3,669          1,436
                                                   --------       --------
      Total current liabilities..................    13,234          7,358

Long-term debt, excluding current portion........    29,432         12,461
Deferred income taxes............................       637            637
Minority interest................................        75             45
                                                   --------       --------
      Total liabilities..........................    43,378         20,501

Stockholders' equity:
  Common stock, $.01 par value, 30,000,000
    shares authorized, 10,708,000 and
    10,527,000 shares issued and outstanding
    at September 30, 1997 and December 31, 1996..       107            106
  Additional paid-in capital.....................    41,863         41,517
  Retained earnings (deficit)....................   (16,274)       (18,083)
                                                   --------       --------
      Total stockholders' equity.................    25,696         23,540
                                                   --------       --------
      Total liabilities and stockholders'
        equity...................................  $ 69,074       $ 44,041
                                                   ========       ========
</TABLE>


    See accompanying notes to condensed consolidated financial statements.

                                       3
<PAGE>
 
                      OPTION CARE, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE
            THREE AND NINE MONTHS ENDED SEPTEMBER 30, 1997 AND 1996
                     (In thousands, except per share data)
                                  (Unaudited)

        
<TABLE>
<CAPTION>
                                     Three Months Ended       Nine Months Ended
                                       September 30,            September 30,
                                      1997       1996         1997       1996
                                     -------    -------      -------    -------
<S>                                  <C>        <C>          <C>        <C>
Revenues:
Patient care services                $22,851    $12,871      $56,511    $36,137
Royalty fees and other                 2,532      2,984        7,918      9,081 
Product sales                          2,307      2,164        6,935      6,617
                                     -------    -------      -------    -------
  Total revenues                      27,690     18,019       71,364     51,835
   
Cost of revenues                      22,395     12,899       56,200     37,106
                                     -------    -------      -------    -------
  Gross profit                         5,295      5,120       15,164     14,729
 
Selling, general and
  administrative expenses              3,354      2,757        9,589      7,967
Provision for doubtful accounts          612        403        1,574      1,376
Amortization of goodwill                 110        222          282        692
                                     -------    -------      -------    -------
  Total operating expenses             4,076      3,382       11,445     10,035
                                     -------    -------      -------    -------
Operating income                       1,219      1,738        3,719      4,694

Other income (expense), net             (414)       (85)        (577)        20
                                     -------    -------      -------    -------
 
Income before income taxes               805      1,653        3,142      4,714
 
Income tax expense                       352        649        1,333      1,994
                                     -------    -------      -------    -------
 
Net income                           $   453    $ 1,004      $ 1,809    $ 2,720
                                     =======    =======      =======    =======
 
Net income per common &
  common equivalent shares           $  0.04    $  0.09      $  0.17    $  0.25
                                     =======    =======      =======    =======
 
Weighted average common &
  common equivalent shares
  outstanding                         10,776     10,776       10,781     10,712
                                     =======    =======      =======    =======
</TABLE>



    See accompanying notes to condensed consolidated financial statements.
                                        

                                       4
<PAGE>
 
                      OPTION CARE, INC. AND SUBSIDIARIES
                CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
                 FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997
                       (In thousands, except share data)
                                  (Unaudited)


<TABLE>
<CAPTION>
                                          Additional                  Total
                                 Common    Paid-in     Retained   Stockholders'
                                  Stock    Capital     Earnings      Equity
                                 -------  ----------  ----------   -----------
<S>                              <C>      <C>         <C>         <C>
Balances, December 31, 1996.....    $106     $41,517    $(18,083)    $23,540
Net income......................     ---         ---       1,809       1,809
Issuance of common stock........       1         346         ---         347
                                    ----     -------    --------     -------
Balances, September 30, 1997....    $107     $41,863    $(16,274)    $25,696
                                    ====     =======    ========     =======

</TABLE>

    See accompanying notes to condensed consolidated financial statements.

                                       5
<PAGE>
 
                      OPTION CARE, INC. AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
             FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997 AND 1996
                                (In thousands)
                                  (Unaudited)
<TABLE>
<CAPTION>
                                                             1997       1996
                                                           ---------  --------
<S>                                                        <C>        <C>
 
Cash flows from operating activities:
  Net income.............................................  $  1,809   $ 2,720
  Adjustments to reconcile net income to net cash
       provided by operating activities:
    Depreciation and amortization........................     1,801     1,781
    Provision for doubtful accounts......................     1,574     1,376
    Change in assets and liabilities net of effects
       from purchase of businesses.......................    (7,761)   (4,472)
                                                           --------   -------
Net cash provided (used) by operating activities.........    (2,577)    1,405
                                                           --------   -------
 
Cash flows from investing activities:
  Additions to other assets..............................    (1,111)   (1,510)
  Payments for acquisitions, net of cash acquired and
       purchases of property and equipment...............   (12,431)   (4,231)
                                                           --------   -------
Net cash used in investing activities....................   (13,542)   (5,741)
                                                           --------   -------
 
Cash flows from financing activities:
  Net borrowings under revolving credit facility.........    16,600     4,100
  Net (payments) borrowing of other long-term debt.......      (965)    1,110
  Proceeds from (repayments of) notes payable............        84      (873)
  Proceeds from issuance of stock........................       347       315
  Distribution from S Corporation........................       ---      ( 84)
                                                           --------   -------
       Net cash provided by financing activities.........    16,066     4,568
                                                           --------   ------- 
                                                           
 
Net increase (decrease) in cash..........................       (53)      232
 
Cash and cash equivalents, beginning of period...........     1,223       502
                                                           --------   -------
 
Cash and cash equivalents, end of period.................  $  1,170   $   734
                                                           ========   =======
</TABLE>

    See accompanying notes to condensed consolidated financial statements.

                                       6

<PAGE>
 
                       OPTION CARE, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (Unaudited)
                          September 30, 1997 and 1996



1.  Basis of Presentation
    ---------------------
 
    The accompanying unaudited condensed consolidated financial statements have
    been prepared in accordance with generally accepted accounting principles
    for interim financial information. Accordingly, they do not include all
    information and footnotes required by generally accepted accounting
    principles for complete financial statements. In the opinion of management,
    all adjustments (consisting of normal recurring accruals) considered
    necessary for a fair presentation have been included. Operating results for
    the nine months ended September 30, 1997 are not necessarily indicative of
    the results that may be expected for the year ended December 31, 1997. For
    further information, refer to the consolidated financial statements and
    footnotes thereto included in the Company's Form 10-K for the year ended
    December 31, 1996.


2.  Recent Accounting Pronouncement
    -------------------------------

    In February, 1997, the Financial Accounting Standards Board issued Statement
    of Financial Accounting Standards ("SFAS") No. 128, "Earnings Per Share"
    ("EPS"). Implementation of SFAS No. 128 is required for the periods ending
    after December 15, 1997. The standard establishes new methods for computing
    and presenting EPS and replaces the presentation of primary and fully-
    diluted EPS with basic and diluted EPS. The new methods under this standard
    are not expected to have a significant impact on the Company's EPS amounts.

                                       7
<PAGE>
 
ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS.


The following discussion should be read in conjunction with the Company's Annual
Report on Form 10-K for the year ended December 31, 1996.  Any forward looking
statements in the following discussion relating to acquisitions or other
business development activities, regulations promulgated since the publication
of the Company's annual report and to future competition or regulation involve
risks and uncertainties that could significantly affect anticipated results in
the future.  These risks and uncertainties include, but are not limited to,
uncertainties relating to acquisitions and divestitures, availability of capital
to fund operations and acquisitions, sales and renewals of franchises,
government and regulatory policies, general economic conditions and changes in
the competitive environment in which the Company operates.


Discussion of Results of Operations for the Third Quarter Ended 
September 30, 1997.

For the quarter ended September 30, 1997, total revenues were $27.7 million, an
increase of $9.7 million or 53.7 percent over the comparable period last year.
Patient care services revenue (revenues generated at Company-owned stores) for
the third quarter were $22.9 million, a $10.0 million or 77.5 percent increase
over the comparable period last year. Royalty fees were $2.5 million in the
third quarter of 1997, a $0.5 million or 15.1 percent decrease over the
comparable period last year.  Product sales for the third quarter were $2.3
million, a $0.1 million or 6.6 percent increase over the comparable period last
year.

The growth in patient care services revenue and decline in royalty fees are
primarily driven by the Company's acquisition strategy which includes the
acquisition of franchise locations. During the quarter ended September 30, 1997,
the Company acquired a franchise office in Grand Haven, Michigan.  This
acquisition along with earlier acquisitions and the resulting shift in revenue
mix is consistent with the Company's strategic shift to being a provider of
comprehensive home health care services with a supporting franchise network
rather than just a franchisor of infusion therapy.

Gross profit for the third quarter of fiscal 1997 increased $0.2 million or 3.4
percent from gross profit for the same period in fiscal 1996.  As a percentage
of revenues, gross profit decreased from 28.4 percent to 19.1 percent in the
third quarter of fiscal 1997.  The decline in gross margin is due primarily to
changes in the Company's revenue mix, specifically the decline in royalty fees
coupled with growth in patient care service revenue.  Revenues from patient care
services (associated with Company-owned Option Care offices) have a higher cost
of revenue than the Company's franchise business, which consists of revenues
from royalty and other fees.

Total operating expenses for the quarter ended September 30, 1997 were $4.1
million, an increase of $0.7 million or 20.5 percent over the comparable period
last year.  Selling, general and administrative expenses were $3.4 million, an
increase of $0.6 million or 21.7 percent over the comparable period last year.
This increase was primarily driven by the Company's software development
business, Management By Information, Inc. (MBI), which was acquired at the end
of August, 1996.  Therefore, only one month of SG&A expenses relating to MBI are
included in the third quarter of 1996 but a full quarter are included in the
third quarter of 1997.  Operating expenses as a percentage of revenue were 14.7
percent for the third quarter of 1997 compared to 18.8 percent for the
comparable period last year.

Other expense for the quarter ended September 30, 1997 was approximately
$414,000.  This consisted of interest expense of approximately $569,000 which
was partially offset by vendor administrative fee income of $132,000.  The
$569,000 in interest expense for the quarter ended September 30, 1997 compares
with $247,000 of interest expense in the comparable period last year.  The
$322,000 increase in interest expense is due to borrowings under the Company's
line of credit to fund acquisitions and related working capital requirements.

Pretax income for the third quarter of fiscal 1997 decreased $0.8 million or
51.3 percent over the comparable period last year, as a result of the decreased
gross profit from the shift in revenue mix, increased operating expenses from
the MBI acquisition and increased interest expense.

                                       8
<PAGE>
 
Net income for the quarter ended September 30, 1997, was $0.5 million, a 54.8
percent decrease compared with net income for the similar period in 1996. The
decrease was caused by the same factors described in the discussion regarding
pretax income.

The effective combined federal and state income tax rate was 43.7 percent in the
third quarter of fiscal 1997 versus 39.3 percent for the third quarter of fiscal
1996. The effective tax rate is higher than the federal statutory tax rate of
34% due to state income taxes and non-tax deductible expenses, primarily
goodwill amortization. The non-deductible portion of the Company's expenses
(primarily goodwill amortization) is essentially fixed, so the effective tax
rate decreases as pretax income increases.


Discussion of Results of Operations for the Nine Months Ended September 30,
1997.

For the nine months ended September 30, 1997, total revenues were $71.4 million,
an increase of $19.5 million or 37.7 percent over the comparable period last
year. Patient care services revenue (revenues generated at Company-owned stores)
for the nine months were $56.5 million, a $20.4 million or 56.4 percent increase
over the comparable period last year. Royalty fees were $7.9 million for the
first nine months of 1997, a $1.2 million or 12.9 percent decrease over the
comparable period last year. Product sales for the nine months ended September
30, 1997 were $6.9 million, a $0.3 million or 4.8 percent increase over the
comparable period last year.

The growth in patient care services revenue and decline in royalty fees are
primarily driven by the Company's acquisition strategy which includes the
acquisition of franchise locations. During the nine months ended September 30,
1997, the Company acquired franchise offices in Ann Arbor and Grand Haven,
Michigan, Miami, Florida, Lincoln and Grand Island, Nebraska, and Victorville
and Vista, California. These acquisitions and the resulting shift in revenue mix
is consistent with the Company's strategic shift to being a provider of
comprehensive home health care services with a supporting franchise network
rather than just a franchisor of infusion therapy.

Gross profit for the first nine months of fiscal 1997 increased $0.4 million or
3.0 percent from gross profit for the same period in fiscal 1996. As a
percentage of revenues, gross profit decreased from 28.4 percent to 21.2 percent
for the first nine months of fiscal 1997. The decline in gross margin is due to
changes in the Company's revenue mix, specifically the decline in royalty fees
coupled with growth in patient care service revenue. Revenues from patient care
services (associated with Company-owned Option Care offices) have a higher cost
of revenue than the Company's franchise business, which consists of revenues
from royalty and other fees.

Total operating expenses for the nine months ended September 30, 1997 were $11.4
million, an increase of $1.4 million or 14.1 percent over the comparable period
last year. Selling, general and administrative expenses were $9.6 million, an
increase of $1.6 million or 20.4 percent compared to the first nine months of
1996. This increase was primarily driven by the Company's software development
business, Management By Information, Inc. (MBI), which was acquired in late
August of 1996. Therefore, only one month of SG&A expenses relating to MBI are
included in the first nine months of 1996 but a full year are included in the
first nine months of 1997.

Other expense for the nine months ended September 30, 1997 was approximately
$577,000. This consisted of interest expense of $1,308,000 which was partially
offset by vendor administrative fee income of $455,000. The $1,308,000 in
interest expense for the nine months ended September 30, 1997 compares with
$684,000 of interest expense in the comparable period last year. The $624,000
increase in interest expense is due to borrowings under the Company's line of
credit to fund acquisitions and related working capital requirements.

Pretax income for the nine months ended September 30, 1997 decreased $1.6
million or 33.3 percent over the comparable period of fiscal 1996, as a result
of the decreased gross profit from the shift in revenue mix, increased operating
expenses from the MBI acquisition and increased interest expense.

Net income for the nine months ended September 30, 1997, was $1.8 million, a
33.5 percent decrease compared with net income for the comparable period last
year. The decrease was caused by the same factors described in the discussion
regarding pretax income.

                                       9
<PAGE>
 
The effective combined federal and state income tax rate was 42.4 percent for
the first nine months of fiscal 1997 versus 42.3 percent for the comparable
period in fiscal 1996. The effective tax rate is higher than the federal
statutory tax rate of 34% due to state income taxes and non-tax deductible
expenses, primarily goodwill amortization. The non-deductible portion of the
Company's expenses (primarily goodwill amortization) is essentially fixed, so
the effective tax rate decreases as pretax income increases.


Liquidity and Capital Resources

As of September 30, 1997, the Company had cash and cash equivalents of $1.2
million.  The Company's working capital at that date was $30.7 million, compared
with $21.4 million at December 31, 1996.  The increase in working capital of
$9.3 million is derived primarily by acquisitions made during the nine month
period ended September 30, 1997.  The Company attempts to manage its cash
balances to minimize interest expense on its line of credit borrowing.

In December 1996, the Company entered into a $30.0 million revolving credit
arrangement, of which there were outstanding borrowings of $28.5 million at
September 30, 1997.  The agreement was amended during the first quarter of 1997
to increase the maximum available amount to $35.0 million.  The covenants under
this credit agreement include, but are not limited to, a minimum interest
coverage ratio, a debt to capitalization ratio and a debt to cash flow ratio.
These covenants restrict the total amount available under the line of credit to
an amount below $35.0 million.  This credit agreement expires and the total
outstanding principal balance is payable in full in December, 1998.  The Company
will be initiating discussions with its senior lenders regarding this credit
agreement and the availability of financing.  There are no assurances that such
financing will be available or available at an acceptable cost.

There are currently various proposals under development to enact health care
reform on a national level.  This would impact the Medicare portion of the home
health care industry. The most active discussions have involved home health
agencies and respiratory therapy providers.  It is not possible at this time to
predict the cash flow impact, if any, such changes may have on Option Care
locations.



Subsequent Events

On November 6, 1997, the Company announced that during the fourth quarter of
1997, the Company will undertake a significant program to restructure certain
key components of its operations both at the corporate office and field
locations.  In addition, the Company is reviewing the valuation of certain
assets.  The restructuring program, and the asset valuation will result in a
fourth quarter after-tax charge ranging from $3.9 to $4.5 million.

Paul S. Jurewicz, Senior Vice-President and Chief Financial Officer, has
tendered his resignation to be effective December 26, 1997.

                                       10
<PAGE>
 
PART II     OTHER INFORMATION

Item 4      Submissions of Matters to a Vote of Security Holders
- ------      ----------------------------------------------------

            None.


Item 6 (a)  Exhibits
- ----------  --------

     11.    Computations of Per Share Earnings


Item 6 (b)  Reports on Form 8-K or Form 8
- ----------  -----------------------------
 
            None.

                                       11
<PAGE>
 
                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.



      
                                        OPTION CARE, INC.


                                        By:      /s/ Paul S. Jurewicz
                                              --------------------------
 
                                              Paul S. Jurewicz
                                              Senior Vice President and
                                              Chief Financial Officer


                                        Date: November 14, 1997

                                       12

<PAGE>
 
                                                                      Exhibit 11



                       OPTION CARE, INC. AND SUBSIDIARIES
                       COMPUTATIONS OF PER SHARE EARNINGS
                       (In thousands, except share data)

<TABLE>
<CAPTION>

                                       THREE MONTHS ENDED       NINE MONTHS ENDED
                                          September 30,           September 30,
                                         1997      1996          1997       1996
                                       -------    -------      -------     -------
<S>                                    <C>        <C>          <C>         <C>
Net income...........................  $   453    $ 1,004      $ 1,809     $ 2,720
                                       =======    =======      =======     =======

Weighted average shares issued.......   10,698     10,496       10,633      10,487
Additional shares included assuming
  exercise of stock options using
  treasury stock method..............       78        280          148         225
                                       -------    -------      -------     -------
Weighted average common shares and
  common share equivalents...........   10,776     10,776       10,781      10,712
                                       =======    =======      =======     =======

Net income per common and common
  equivalent share...................  $  0.04    $  0.09      $  0.17     $  0.25
                                       =======    =======      =======     =======
</TABLE>

                                      13

<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>                     <C> 
<PERIOD-TYPE>                   3-MOS                   YEAR      
<FISCAL-YEAR-END>                         DEC-31-1997            DEC-31-1997  
<PERIOD-START>                            JAN-01-1997            JAN-01-1997   
<PERIOD-END>                              SEP-30-1997            SEP-30-1997  
<CASH>                                      1,170,000              1,170,000  
<SECURITIES>                                        0                      0 
<RECEIVABLES>                              34,254,000             34,254,000 
<ALLOWANCES>                                        0                      0 
<INVENTORY>                                 2,576,000              2,576,000 
<CURRENT-ASSETS>                           43,917,000             43,917,000
<PP&E>                                      5,986,000              5,986,000
<DEPRECIATION>                                      0                      0   
<TOTAL-ASSETS>                             69,074,000             69,074,000
<CURRENT-LIABILITIES>                      13,234,000             13,234,000   
<BONDS>                                             0                      0 
                               0                      0 
                                         0                      0 
<COMMON>                                      107,000                107,000 
<OTHER-SE>                                 25,589,000             25,589,000
<TOTAL-LIABILITY-AND-EQUITY>               69,074,000             69,074,000
<SALES>                                             0                      0  
<TOTAL-REVENUES>                           27,690,000             71,364,000
<CGS>                                      22,395,000             56,200,000
<TOTAL-COSTS>                               4,076,000             11,445,000 
<OTHER-EXPENSES>                            (414,000)              (577,000)
<LOSS-PROVISION>                              612,000              1,574,000
<INTEREST-EXPENSE>                            569,000              1,308,000
<INCOME-PRETAX>                               805,000              3,142,000
<INCOME-TAX>                                  352,000              1,333,000
<INCOME-CONTINUING>                                 0                      0
<DISCONTINUED>                                      0                      0 
<EXTRAORDINARY>                                     0                      0
<CHANGES>                                           0                      0 
<NET-INCOME>                                  453,000              1,809,000 
<EPS-PRIMARY>                                       0                      0 
<EPS-DILUTED>                                    0.04                   0.17 
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission